Abstract:
Background: Chronic lymphatic injury—frequently driven by vector-borne neglected tropical diseases (NTDs) such as lymphatic filariasis, alongside conditions like malaria and schistosomiasis—poses a critical but overlooked threat to global cardiometabolic health. In low-resource and disaster-prone settings, the lack of specialized clinical infrastructure exacerbates secondary cardiovascular complications, including systemic inflammation, accelerated atherosclerosis, and metabolic syndrome. This study evaluates the efficacy of low-cost, non-invasive lymphatic modulation techniques to improve cardiometabolic outcomes in vulnerable populations.
Methods: A randomized controlled trial was conducted across rural clinics in sub-Saharan Africa, involving 450 participants diagnosed with chronic lymphatic filariasis or secondary lymphedema. Participants were assigned to either a standard care control group or an intervention group receiving simplified, non-invasive manual lymphatic drainage protocols combined with localized compression therapy. Cardiometabolic markers, including high-sensitivity C-reactive protein (hs-CRP), blood pressure, arterial stiffness via pulse wave velocity, and lipid profiles, were monitored over a 12-month period.
Results: The intervention group demonstrated a statistically significant reduction in systemic inflammatory markers, with hs-CRP levels decreasing by an average of 28% compared to the control group. Furthermore, non-invasive lymphatic modulation led to a meaningful reduction in systolic blood pressure (-6.5 mmHg) and improved arterial elasticity. These positive cardiovascular outcomes correlated directly with a reduction in localized tissue volume and improved lymphatic flow.
Conclusions: Non-invasive lymphatic modulation represents a scalable, highly effective, and low-cost intervention that mitigates secondary cardiometabolic risks in resource-limited regions. Integrating basic lymphatic care into primary healthcare systems and disaster-response protocols can significantly reduce the long-term global burden of cardiovascular morbidity associated with neglected tropical diseases.
Biography:
Jeyatheepan Jeyaretnam is a physician-scientist and public health researcher specializing in global health interventions, with a distinct focus on the intersection of neglected tropical diseases (NTDs) and chronic cardiometabolic sequelae. He holds a Doctorate in Medicine (MD) and an Advanced Master of Science in Biomedical Sciences, with the specialization in Immunology and Infectious Diseases. Jeyaretnam has actively collaborated with prominent global health institutions and non-governmental organizations to pioneer sustainable, low-cost clinical protocols tailored for disaster-prone and resource-limited settings. His current translational research evaluates non-invasive therapeutic modalities designed to mitigate secondary cardiovascular risks in highly vulnerable populations worldwide.
© 2026 Mathews International LLC. All rights reserved.
